Fibroma natural history: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by one other user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}}{{M.N}}, {{Simrat}}
{{CMG}}; {{AE}}{{M.N}}, {{Simrat}}
==Overview==
==Overview==
Common [[complications]] of [[chondromyxoid]], [[ossifying]] and [[non-ossifying fibroma]] include [[pathological]] [[fractures]]. Depending on the type of the fibroma, the [[prognosis]] may vary. However, the [[prognosis]] is generally regarded as excellent for nonossifying fibroma. Ossifying fibromas tend to regress over time. Ossifying fibroma is noninvasive [[tumor]]. It will recur if it is excised before [[skeletal]] maturity. [[Excision]] after [[skeletal]] maturity is usually successful. [[Oral fibromas]] are [[benign]] tumors. Recurrence of oral fibromas is possible, however, if the offending irritant persists. [[Desmoplastic fibromas]] are benign and locally aggressive [[tumors]]. Desmoplastic fibroma is a rare [[benign]] [[intraosseous]] [[tumor]] [[neoplasm]]. Desmoplastic fibroma has a recurrence rate of approximately 37% to 72%. The average rate of recurrence after curettage has been reported to be approximately 55%.<ref name="pmid23459513">{{cite journal| author=Nedopil A, Raab P, Rudert M| title=Desmoplastic fibroma: a case report with three years of clinical and radiographic observation and review of the literature. | journal=Open Orthop J | year= 2013 | volume= 8 | issue=  | pages= 40-6 | pmid=23459513 | doi=10.2174/1874325001307010040 | pmc=PMC3583030 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23459513  }} </ref><ref name="pmid11856945">{{cite journal| author=Biermann JS| title=Common benign lesions of bone in children and adolescents. | journal=J Pediatr Orthop | year= 2002 | volume= 22 | issue= 2 | pages= 268-73 | pmid=11856945 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11856945  }} </ref><ref name="ChengJi2012">{{cite journal|last1=Cheng|first1=A.|last2=Ji|first2=S.|last3=Pogrel|first3=M.A.|title=Poster 55: A Natural History of Desmoplastic Fibroma: Over 20 Years of Experience|journal=Journal of Oral and Maxillofacial Surgery|volume=70|issue=9|year=2012|pages=e74|issn=02782391|doi=10.1016/j.joms.2012.06.111}}</ref>
Common [[complications]] of [[chondromyxoid]], [[ossifying]] and [[non-ossifying fibroma]] include [[pathological]] [[fractures]]. Depending on the type of the fibroma, the [[prognosis]] may vary. However, the [[prognosis]] is generally regarded as excellent for nonossifying fibroma. Ossifying fibromas tend to regress over time. Ossifying fibroma is noninvasive [[tumor]]. It will recur if it is excised before [[skeletal]] maturity. [[Excision]] after [[skeletal]] maturity is usually successful. [[Oral fibromas]] are [[benign]] tumors. Recurrence of oral fibromas is possible, however, if the offending irritant persists. [[Desmoplastic fibromas]] are benign and locally aggressive [[tumors]]. Desmoplastic fibroma is a rare [[benign]] [[intraosseous]] [[tumor]] [[neoplasm]]. Desmoplastic fibroma has a recurrence rate of approximately 37% to 72%. The average rate of recurrence after curettage has been reported to be approximately 55%.


==Natural History==
==Natural History==
Line 14: Line 14:


===Chondromyxoid Fibroma===
===Chondromyxoid Fibroma===
[[Chondromyxoid fibroma]] (CMF) is a rare, slow-growing, [[benign]] [[bone tumor]] of chondroblastic derivation. Approximately 70% of patients with chondromyxoid fibroma have [[symptoms]] at the time of [[diagnosis]]; the remaining [[lesions]] are found incidentally. Chondromyxoid fibroma (CMF) represents less than 1% of all [[benign]] [[bone neoplasms]]. It is a slow-growing, locally destructive [[tumor]].<ref name="KhalatbariHamidi2012">{{cite journal|last1=Khalatbari|first1=Mahmoud|last2=Hamidi|first2=Mehrdokht|last3=Moharamzad|first3=Yashar|title=Chondromyxoid Fibroma of the Anterior Skull Base Invading the Orbit in a Pediatric Patient: Case Report and Review of the Literature|journal=Neuropediatrics|volume=43|issue=03|year=2012|pages=140–145|issn=0174-304X|doi=10.1055/s-0032-1307460}}</ref> [[Pain]] is the most common [[symptom]] and may be present for years. While typically mild, the [[pain]] may become severe with time, and night [[symptoms]] may be present. [[Patients]] may also report [[stiffness]] and [[swelling]]. As a consequence of slow growth of the [[tumor]], [[Pathological|pathologic]] [[fractures]] have been rarely reported. Chondromyxoid fibroma is an unusual [[benign]] [[tumor]] of [[cartilaginous]] [[tissues]].<ref name="E.E.2005">{{cite journal|last1=E.|first1=Estrada-Villaseñor|last2=E.|first2=Delgado Cedillo|last3=G.|first3=Rico Martínez|last4=R.|first4=Delgado Chávez|title=Periosteal chondromyxoid fibroma: A case study using imprint cytology|journal=Diagnostic Cytopathology|volume=33|issue=6|year=2005|pages=402–406|issn=8755-1039|doi=10.1002/dc.20357}}</ref><ref name="pmid7761324">{{cite journal| author=McGrory BJ, Inwards CY, McLeod RA, Sim FH| title=Chondromyxoid fibroma. | journal=Orthopedics | year= 1995 | volume= 18 | issue= 3 | pages= 307-10 | pmid=7761324 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7761324  }} </ref><ref name="pmid8717127">{{cite journal| author=White PG, Saunders L, Orr W, Friedman L| title=Chondromyxoid fibroma. | journal=Skeletal Radiol | year= 1996 | volume= 25 | issue= 1 | pages= 79-81 | pmid=8717127 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8717127  }} </ref><ref name="pmid5110934">{{cite journal| author=Schutt PG, Frost HM| title=Chondromyxoid fibroma. | journal=Clin Orthop Relat Res | year= 1971 | volume= 78 | issue=  | pages= 323-9 | pmid=5110934 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5110934  }} </ref><ref name="pmid14038586">{{cite journal| author=RALPH LL| title=Chondromyxoid fibroma of bone. | journal=J Bone Joint Surg Br | year= 1962 | volume= 44-B | issue=  | pages= 7-24 | pmid=14038586 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14038586  }} </ref>
 
* [[Chondromyxoid fibroma]] (CMF) is a rare, slow-growing, [[benign]] [[bone tumor]] of chondroblastic derivation. Approximately 70% of patients with chondromyxoid fibroma have [[symptoms]] at the time of [[diagnosis]]; the remaining [[lesions]] are found incidentally. Chondromyxoid fibroma (CMF) represents less than 1% of all [[benign]] [[bone neoplasms]]. It is a slow-growing, locally destructive [[tumor]].<ref name="KhalatbariHamidi2012">{{cite journal|last1=Khalatbari|first1=Mahmoud|last2=Hamidi|first2=Mehrdokht|last3=Moharamzad|first3=Yashar|title=Chondromyxoid Fibroma of the Anterior Skull Base Invading the Orbit in a Pediatric Patient: Case Report and Review of the Literature|journal=Neuropediatrics|volume=43|issue=03|year=2012|pages=140–145|issn=0174-304X|doi=10.1055/s-0032-1307460}}</ref> [[Pain]] is the most common [[symptom]] and may be present for years. While typically mild, the [[pain]] may become severe with time, and night [[symptoms]] may be present. [[Patients]] may also report [[stiffness]] and [[swelling]]. As a consequence of slow growth of the [[tumor]], [[Pathological|pathologic]] [[fractures]] have been rarely reported. Chondromyxoid fibroma is an unusual [[benign]] [[tumor]] of [[cartilaginous]] [[tissues]].<ref name="E.E.2005">{{cite journal|last1=E.|first1=Estrada-Villaseñor|last2=E.|first2=Delgado Cedillo|last3=G.|first3=Rico Martínez|last4=R.|first4=Delgado Chávez|title=Periosteal chondromyxoid fibroma: A case study using imprint cytology|journal=Diagnostic Cytopathology|volume=33|issue=6|year=2005|pages=402–406|issn=8755-1039|doi=10.1002/dc.20357}}</ref><ref name="pmid7761324">{{cite journal| author=McGrory BJ, Inwards CY, McLeod RA, Sim FH| title=Chondromyxoid fibroma. | journal=Orthopedics | year= 1995 | volume= 18 | issue= 3 | pages= 307-10 | pmid=7761324 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7761324  }} </ref><ref name="pmid8717127">{{cite journal| author=White PG, Saunders L, Orr W, Friedman L| title=Chondromyxoid fibroma. | journal=Skeletal Radiol | year= 1996 | volume= 25 | issue= 1 | pages= 79-81 | pmid=8717127 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8717127  }} </ref><ref name="pmid5110934">{{cite journal| author=Schutt PG, Frost HM| title=Chondromyxoid fibroma. | journal=Clin Orthop Relat Res | year= 1971 | volume= 78 | issue=  | pages= 323-9 | pmid=5110934 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5110934  }} </ref><ref name="pmid14038586">{{cite journal| author=RALPH LL| title=Chondromyxoid fibroma of bone. | journal=J Bone Joint Surg Br | year= 1962 | volume= 44-B | issue=  | pages= 7-24 | pmid=14038586 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14038586  }} </ref>
===Oral Fibroma===
===Oral Fibroma===


Line 50: Line 51:
==Prognosis==
==Prognosis==
===Non-ossifying Fibroma===
===Non-ossifying Fibroma===
Generally, the [[prognosis]] for nonossifying fibroma is excellent. They usually fill in during [[adolescence]]. The risk of recurrence is usually lower than for other [[benign tumors]].<ref name="pmid11856945">{{cite journal| author=Biermann JS| title=Common benign lesions of bone in children and adolescents. | journal=J Pediatr Orthop | year= 2002 | volume= 22 | issue= 2 | pages= 268-73 | pmid=11856945 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11856945  }} </ref>
 
* Generally, the [[prognosis]] for nonossifying fibroma is excellent. They usually fill in during [[adolescence]]. The risk of recurrence is usually lower than for other [[benign tumors]].<ref name="pmid11856945">{{cite journal| author=Biermann JS| title=Common benign lesions of bone in children and adolescents. | journal=J Pediatr Orthop | year= 2002 | volume= 22 | issue= 2 | pages= 268-73 | pmid=11856945 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11856945  }} </ref>
===Oral Fibromas===
===Oral Fibromas===
[[Oral fibromas]] are [[benign tumors]]. Recurrence of oral fibromas is possible, however, if the offending [[irritant]] persists.
 
* [[Oral fibromas]] are [[benign tumors]]. Recurrence of oral fibromas is possible, however, if the offending [[irritant]] persists.
===Ovarian Fibromas===
===Ovarian Fibromas===
[[Ovarian fibromas]] are almost always [[benign]].  
 
* [[Ovarian fibromas]] are almost always [[benign]].  
===Ossifying Fibroma===
===Ossifying Fibroma===
[[Ossifying fibromas]] tend to regress over time. For locally aggressive [[lesions]], [[surgical resection]] is often curative although recurrence has been reported. Ossifying fibroma is [[noninvasive]] [[tumor]]. It will recur if it is excised before [[skeletal]] maturity. [[Excision]] after [[skeletal]] maturity is usually successful.<ref name="pmid14620087">{{cite journal| author=McCaffrey M, Letts M, Carpenter B, Kabir A, Davidson D, Seip J| title=Osteofibrous dysplasia: a review of the literature and presentation of an additional 3 cases. | journal=Am J Orthop (Belle Mead NJ) | year= 2003 | volume= 32 | issue= 10 | pages= 479-86 | pmid=14620087 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14620087  }} </ref><ref name="pmid1563159">{{cite journal| author=Wang JW, Shih CH, Chen WJ| title=Osteofibrous dysplasia (ossifying fibroma of long bones). A report of four cases and review of the literature. | journal=Clin Orthop Relat Res | year= 1992 | volume=  | issue= 278 | pages= 235-43 | pmid=1563159 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1563159  }} </ref>
 
* [[Ossifying fibromas]] tend to regress over time. For locally aggressive [[lesions]], [[surgical resection]] is often curative although recurrence has been reported. Ossifying fibroma is [[noninvasive]] [[tumor]]. It will recur if it is excised before [[skeletal]] maturity. [[Excision]] after [[skeletal]] maturity is usually successful.<ref name="pmid14620087">{{cite journal| author=McCaffrey M, Letts M, Carpenter B, Kabir A, Davidson D, Seip J| title=Osteofibrous dysplasia: a review of the literature and presentation of an additional 3 cases. | journal=Am J Orthop (Belle Mead NJ) | year= 2003 | volume= 32 | issue= 10 | pages= 479-86 | pmid=14620087 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14620087  }} </ref><ref name="pmid1563159">{{cite journal| author=Wang JW, Shih CH, Chen WJ| title=Osteofibrous dysplasia (ossifying fibroma of long bones). A report of four cases and review of the literature. | journal=Clin Orthop Relat Res | year= 1992 | volume=  | issue= 278 | pages= 235-43 | pmid=1563159 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1563159  }} </ref>


===Pleural Fibroma===
===Pleural Fibroma===
Line 68: Line 73:


===Chondromyxoid-Fibroma===
===Chondromyxoid-Fibroma===
Chondromyxoid-fibroma are [[benign]] [[lesions]] and [[malignant]] [[degeneration]] is rare. Chondromyxoid-fibromas have a high recurrence rate of approximately 25%.  
 
* Chondromyxoid-fibroma are [[benign]] [[lesions]] and [[malignant]] [[degeneration]] is rare. Chondromyxoid-fibromas have a high recurrence rate of approximately 25%.  
===Cemento-ossifying Fibroma===
===Cemento-ossifying Fibroma===
Recurrence following complete [[excision]] of cemento-ossifying fibroma is generally considered to be uncommon. However, in some series, it has been reported to be approximately 16%.
 
* Recurrence following complete [[excision]] of cemento-ossifying fibroma is generally considered to be uncommon. However, in some series, it has been reported to be approximately 16%.


===Desmoplastic Fibroma===
===Desmoplastic Fibroma===
[[Desmoplastic fibromas]] are [[benign]] and locally aggressive [[tumors]]. Desmoplastic fibroma is a rare [[benign]] [[intraosseous]] [[tumor]] [[neoplasm]]. It is usually a localized [[lesion]] with propensity for [[cortical bone]] [[perforation]] and recurrence. They are considered to be a bony counterpart of [[soft tissue]] [[Desmoid tumor|desmoid tumors]] and are [[histologically]] identical. <ref name="ChengJi2012">{{cite journal|last1=Cheng|first1=A.|last2=Ji|first2=S.|last3=Pogrel|first3=M.A.|title=Poster 55: A Natural History of Desmoplastic Fibroma: Over 20 Years of Experience|journal=Journal of Oral and Maxillofacial Surgery|volume=70|issue=9|year=2012|pages=e74|issn=02782391|doi=10.1016/j.joms.2012.06.111}}</ref> Desmoplastic fibroma has a recurrence rate of approximately 37% to 72%. The average rate of recurrence after [[curettage]] has been reported to be approximately 55%.<ref name="pmid23459513">{{cite journal| author=Nedopil A, Raab P, Rudert M| title=Desmoplastic fibroma: a case report with three years of clinical and radiographic observation and review of the literature. | journal=Open Orthop J | year= 2013 | volume= 8 | issue=  | pages= 40-6 | pmid=23459513 | doi=10.2174/1874325001307010040 | pmc=PMC3583030 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23459513  }} </ref>
 
* [[Desmoplastic fibromas]] are [[benign]] and locally aggressive [[tumors]]. Desmoplastic fibroma is a rare [[benign]] [[intraosseous]] [[tumor]] [[neoplasm]]. It is usually a localized [[lesion]] with propensity for [[cortical bone]] [[perforation]] and recurrence. They are considered to be a bony counterpart of [[soft tissue]] [[Desmoid tumor|desmoid tumors]] and are [[histologically]] identical. <ref name="ChengJi2012">{{cite journal|last1=Cheng|first1=A.|last2=Ji|first2=S.|last3=Pogrel|first3=M.A.|title=Poster 55: A Natural History of Desmoplastic Fibroma: Over 20 Years of Experience|journal=Journal of Oral and Maxillofacial Surgery|volume=70|issue=9|year=2012|pages=e74|issn=02782391|doi=10.1016/j.joms.2012.06.111}}</ref> Desmoplastic fibroma has a recurrence rate of approximately 37% to 72%. The average rate of recurrence after [[curettage]] has been reported to be approximately 55%.<ref name="pmid23459513">{{cite journal| author=Nedopil A, Raab P, Rudert M| title=Desmoplastic fibroma: a case report with three years of clinical and radiographic observation and review of the literature. | journal=Open Orthop J | year= 2013 | volume= 8 | issue=  | pages= 40-6 | pmid=23459513 | doi=10.2174/1874325001307010040 | pmc=PMC3583030 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23459513  }} </ref>
===Sclerotic Fibroma===
===Sclerotic Fibroma===
[[Sclerotic fibroma]] is an uncommon [[benign]] [[Fibrous|fibrou]]<nowiki/>s [[neoplasm]] and may be [[solitary]] or multifocal.
 
* [[Sclerotic fibroma]] is an uncommon [[benign]] [[Fibrous|fibrou]]<nowiki/>s [[neoplasm]] and may be [[solitary]] or multifocal.
===Uterine Fibroma===
===Uterine Fibroma===
About 1 out of 1000 [[lesions]] are or become [[malignant]], typically as a [[leiomyosarcoma]] on [[histology]]. A [[Sign (medicine)|sign]] that a [[lesion]] may be [[malignant]] is growth after [[menopause]]. There are a number of [[rare]] [[conditions]] in which [[fibroids]] [[metastasize]]. They still grow in a [[benign]] fashion, but can be dangerous depending on their [[Location parameter|location]].
 
* About 1 out of 1000 [[lesions]] are or become [[malignant]], typically as a [[leiomyosarcoma]] on [[histology]]. A [[Sign (medicine)|sign]] that a [[lesion]] may be [[malignant]] is growth after [[menopause]]. There are a number of [[rare]] [[conditions]] in which [[fibroids]] [[metastasize]]. They still grow in a [[benign]] fashion, but can be dangerous depending on their [[Location parameter|location]].
===Peripheral odontogenic fibroma===
===Peripheral odontogenic fibroma===
Recurrence is [[rare]]
 
* Recurrence is [[rare]]
===Giant cell fibroma===
===Giant cell fibroma===
[[Giant cell fibroma]] is a [[benign]] non-neoplastic [[lesion]]. Recurrence is [[rare]].
 
* [[Giant cell fibroma]] is a [[benign]] non-neoplastic [[lesion]]. Recurrence is [[rare]].


==References==
==References==

Latest revision as of 14:38, 16 September 2019

Fibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Fibroma from other Diseases

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Fibroma natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibroma natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroma natural history

CDC on Fibroma natural history

Fibroma natural history in the news

Blogs on Fibroma natural history

Directions to Hospitals Treating Fibroma

Risk calculators and risk factors for Fibroma natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2], Simrat Sarai, M.D. [3]

Overview

Common complications of chondromyxoid, ossifying and non-ossifying fibroma include pathological fractures. Depending on the type of the fibroma, the prognosis may vary. However, the prognosis is generally regarded as excellent for nonossifying fibroma. Ossifying fibromas tend to regress over time. Ossifying fibroma is noninvasive tumor. It will recur if it is excised before skeletal maturity. Excision after skeletal maturity is usually successful. Oral fibromas are benign tumors. Recurrence of oral fibromas is possible, however, if the offending irritant persists. Desmoplastic fibromas are benign and locally aggressive tumors. Desmoplastic fibroma is a rare benign intraosseous tumor neoplasm. Desmoplastic fibroma has a recurrence rate of approximately 37% to 72%. The average rate of recurrence after curettage has been reported to be approximately 55%.

Natural History

Cemento-ossifying fibroma

  • Clinically, cemento-ossifying fibroma manifest as a slow-growing intrabony mass that is normally well delimited and asymptomatic, although over time the lesion may become large enough to cause facial deformation. Cemento-ossifying fibroma is a benign fibro-osseous maxillary tumor. It is a slow-growing lesion. Approximately one-half of all cases are asymptomatic, the growth of the tumor over time may lead to facial asymmetry, with the appearance of a mass causing facial discomfort or mandibular expansion, and the possible displacement of dental roots. Juvenile aggressive cemento-ossifying fibroma presents in children and is clinically more aggressive and pathologically more vascular.[1]


Chondromyxoid Fibroma

Oral Fibroma

Desmoplastic Fibroma

  • Desmoplastic fibroma (DF) is an extremely rare benign intraosseous tumor with locally aggressive and infiltrative characteristics. The clinical presentation of desmoplastic fibroma is nonspecific and usually presents as pain over the affected area and occasionally as a palpable mass, although pathologic fracture has been described previously as a common reason for seeking treatment. Desmoplastic fibroma has also been presented as an incidental finding. The most common sites of involvement are the mandible and the metaphysis of long bones. Biologically and histologically, desmoplastic fibroma mimics extra-abdominal desmoid tumor of soft tissue. Morphologically a distinction between desmoplastic fibroma and aggressive fibromatosis (desmoid tumor) is not possible.[17][18][19]

Non-ossifying Fibroma

Complications

Ovarian Fibroma

Ossifying- Fibroma

Non-ossifying Fibroma

Chondromyxoid fibromas

Uterine Fibromas

Prognosis

Non-ossifying Fibroma

Oral Fibromas

Ovarian Fibromas

Ossifying Fibroma

Pleural Fibroma

Chondromyxoid-Fibroma

Cemento-ossifying Fibroma

  • Recurrence following complete excision of cemento-ossifying fibroma is generally considered to be uncommon. However, in some series, it has been reported to be approximately 16%.

Desmoplastic Fibroma

Sclerotic Fibroma

Uterine Fibroma

Peripheral odontogenic fibroma

Giant cell fibroma

References

  1. Silvestre-Rangil, J.; Silvestre, FJ.; Requeni-Bernal, J. (2011). "Cemento-ossifying fibroma of the mandible: Presentation of a case and review of the literature". Journal of Clinical and Experimental Dentistry: e66–e69. doi:10.4317/jced.3.e66. ISSN 1989-5488.
  2. Hekmatnia A, Ghazavi A, Saboori M, Mahzouni P, Tayari N, Hekmatnia F (2011). "A case report of cemento-ossifying fibroma presenting as a mass of the ethmoid sinus". J Res Med Sci. 16 (2): 224–8. PMC 3214308. PMID 22091236.
  3. Naik RM, Guruprasad Y, Sujatha D, Gurudath S, Pai A, Suresh K (January 2014). "Giant cemento-ossifying fibroma of the mandible". J Nat Sci Biol Med. 5 (1): 190–4. doi:10.4103/0976-9668.127326. PMC 3961933. PMID 24678226.
  4. Jayachandran S, Meenakshi R (2004). "Cemento ossifying fibroma". Indian J Dent Res. 15 (1): 35–9. PMID 15682795.
  5. El-Mofty SK (November 1999). "Cemento-ossifying fibroma and benign cementoblastoma". Semin Diagn Pathol. 16 (4): 302–7. PMID 10587273.
  6. Dewan HS, Dewan SK, Bahl S, Tushar Parekh P (October 2016). "Cemento-ossifying fibroma of mandible mimicking complex composite odontome". BMJ Case Rep. 2016. doi:10.1136/bcr-2016-216053. PMC 5073669. PMID 27797795.
  7. Khalatbari, Mahmoud; Hamidi, Mehrdokht; Moharamzad, Yashar (2012). "Chondromyxoid Fibroma of the Anterior Skull Base Invading the Orbit in a Pediatric Patient: Case Report and Review of the Literature". Neuropediatrics. 43 (03): 140–145. doi:10.1055/s-0032-1307460. ISSN 0174-304X.
  8. E., Estrada-Villaseñor; E., Delgado Cedillo; G., Rico Martínez; R., Delgado Chávez (2005). "Periosteal chondromyxoid fibroma: A case study using imprint cytology". Diagnostic Cytopathology. 33 (6): 402–406. doi:10.1002/dc.20357. ISSN 8755-1039.
  9. McGrory BJ, Inwards CY, McLeod RA, Sim FH (1995). "Chondromyxoid fibroma". Orthopedics. 18 (3): 307–10. PMID 7761324.
  10. White PG, Saunders L, Orr W, Friedman L (1996). "Chondromyxoid fibroma". Skeletal Radiol. 25 (1): 79–81. PMID 8717127.
  11. Schutt PG, Frost HM (1971). "Chondromyxoid fibroma". Clin Orthop Relat Res. 78: 323–9. PMID 5110934.
  12. RALPH LL (1962). "Chondromyxoid fibroma of bone". J Bone Joint Surg Br. 44-B: 7–24. PMID 14038586.
  13. Regezi, Joseph A., James J. Sciubba, and Richard C. Jordan. Oral Pathology Clinical Pathologic Correlations. City: Elsevier Health Sciences, 2015. Print.
  14. Rangeeth, B. N., Joyson Moses, and Veera Kishore Kumar Reddy. "A rare presentation of mucocele and irritation fibroma of the lower lip." Contemporary clinical dentistry 1.2 (2010): 111.
  15. Vilmann, A., P. Vilmann, and H. Vilmann. "Pyogenic granuloma: evaluation of oral conditions." British journal of oral and Maxillofacial surgery 24.5 (1986): 376-382.
  16. Kolte, Abhay P., Rajshri A. Kolte, and Tushar S. Shrirao. "Focal fibrous overgrowths: A case series and review of literature." Contemporary clinical dentistry 1.4 (2010): 271.
  17. 17.0 17.1 Nedopil A, Raab P, Rudert M (2013). "Desmoplastic fibroma: a case report with three years of clinical and radiographic observation and review of the literature". Open Orthop J. 8: 40–6. doi:10.2174/1874325001307010040. PMC 3583030. PMID 23459513.
  18. Schneider M, Zimmermann AC, Depprich RA, Kübler NR, Engers R, Naujoks CD, Handschel J (November 2009). "Desmoplastic fibroma of the mandible--review of the literature and presentation of a rare case". Head Face Med. 5: 25. doi:10.1186/1746-160X-5-25. PMC 2787487. PMID 19930688.
  19. Apaydin M, Gelal F, Avci A, Adinas C, Sarsilmaz A, Varer M (October 2008). "Desmoplastic fibroma in humerus". J Med Imaging Radiat Oncol. 52 (5): 489–90. doi:10.1111/j.1440-1673.2008.01989.x. PMID 19032395.
  20. Bowers LM, Cohen DM, Bhattacharyya I, Pettigrew JC, Stavropoulos MF (2013). "The non-ossifying fibroma: a case report and review of the literature". Head Neck Pathol. 7 (2): 203–10. doi:10.1007/s12105-012-0399-7. PMC 3642261. PMID 23008139.
  21. Sakamoto, Akio; Ishii, Takeaki; Oda, Yoshinao; Iwamoto, Yukihide (2012). "Nonossifying fibroma presenting as an aneurysmal bone cyst: a case report". Journal of Medical Case Reports. 6 (1): 407. doi:10.1186/1752-1947-6-407. ISSN 1752-1947.
  22. Bowers, Leah M.; Cohen, Donald M.; Bhattacharyya, Indraneel; Pettigrew, James C.; Stavropoulos, Mary F. (2012). "The Non-ossifying Fibroma: A Case Report and Review of the Literature". Head and Neck Pathology. 7 (2): 203–210. doi:10.1007/s12105-012-0399-7. ISSN 1936-055X.
  23. Herget GW, Mauer D, Krauß T, El Tayeh A, Uhl M, Südkamp NP, Hauschild O (April 2016). "Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow-up". BMC Musculoskelet Disord. 17: 147. doi:10.1186/s12891-016-1004-0. PMC 4820930. PMID 27044378.
  24. Macciò A, Madeddu C, Kotsonis P, Pietrangeli M, Paoletti AM (June 2014). "Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery". BMC Surg. 14: 38. doi:10.1186/1471-2482-14-38. PMC 4074309. PMID 24962423.
  25. Okuda K, Noguchi S, Narumoto O, Ikemura M, Yamauchi Y, Tanaka G, Takai D, Fukayama M, Nagase T (May 2016). "A case of Meigs' syndrome with preceding pericardial effusion in advance of pleural effusion". BMC Pulm Med. 16 (1): 71. doi:10.1186/s12890-016-0241-1. PMC 4862177. PMID 27160723.
  26. Kortekaas KE, Pelikan HM (January 2018). "Hydrothorax, ascites and an abdominal mass: not always signs of a malignancy - Three cases of Meigs' syndrome". J Radiol Case Rep. 12 (1): 17–26. doi:10.3941/jrcr.v12i1.3209. PMID 29875983.
  27. "Bleeding associated with uterine leiomyomas. Tailor treatment to the individual patient". Prescrire Int. 23 (149): 130–5. May 2014. PMID 24926520.
  28. Althobaiti FA, Alsaadi KK, Althobaiti AA (February 2019). "A Case of Hemoperitoneum Due to Spontaneous Bleeding from a Uterine Leiomyoma". Am J Case Rep. 20: 167–170. doi:10.12659/AJCR.914573. PMC 6375281. PMID 30733430.
  29. Mizrahi DJ, Kaushik C, Adamo R (March 2017). "Hypovolemic Shock and Hemoperitoneum from Spontaneous Avulsion of a Large Pedunculated Uterine Leiomyoma". J Radiol Case Rep. 11 (3): 15–21. doi:10.3941/jrcr.v11i3.3054. PMC 5441463. PMID 28584568.
  30. Pachy F, Lemercier D, Dommergues M, Sibony O (May 2009). "[Unusual complication of uterine leiomyoma: spontaneous avulsion with massive hemoperitoneum]". J Gynecol Obstet Biol Reprod (Paris) (in French). 38 (3): 239–41. doi:10.1016/j.jgyn.2008.08.008. PMID 19179018.
  31. Hicks G, McCallum IJ, Ogah K, Guirguis M, Kasaraneni R (February 2010). "Spontaneous uterine perforation secondary to uterine leiomyosarcoma presenting as acute abdomen with haemoperitoneum". J Obstet Gynaecol. 30 (2): 211–2. doi:10.3109/01443610903477523. PMID 20143996.
  32. Biermann JS (2002). "Common benign lesions of bone in children and adolescents". J Pediatr Orthop. 22 (2): 268–73. PMID 11856945.
  33. McCaffrey M, Letts M, Carpenter B, Kabir A, Davidson D, Seip J (2003). "Osteofibrous dysplasia: a review of the literature and presentation of an additional 3 cases". Am J Orthop (Belle Mead NJ). 32 (10): 479–86. PMID 14620087.
  34. Wang JW, Shih CH, Chen WJ (1992). "Osteofibrous dysplasia (ossifying fibroma of long bones). A report of four cases and review of the literature". Clin Orthop Relat Res (278): 235–43. PMID 1563159.
  35. Cheng, A.; Ji, S.; Pogrel, M.A. (2012). "Poster 55: A Natural History of Desmoplastic Fibroma: Over 20 Years of Experience". Journal of Oral and Maxillofacial Surgery. 70 (9): e74. doi:10.1016/j.joms.2012.06.111. ISSN 0278-2391.


Template:WikiDoc Sources